The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Single-agent BRAF inhibitors have been largely ineffective in BRAF MT CRCs (19), despite activity in BRAF MT melanomas (20).”
From mTOR Inhibition Specifically Sensitizes Colorectal Cancers with KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1 (2014) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Research works printed but not linked: 28
- Comis RL, 1976, Cancer Treat Rep, 60, 165
- Atkins MB, 1999, J Clin Oncol, 17, 2105, 10.1200/JCO.1999.17.7.2105 · DOI
- Middleton MR, 2000, J Clin Oncol, 18, 158, 10.1200/JCO.2000.18.1.158 · DOI
- 10.1200/JCO.2006.06.0483 · DOI
- 10.1210/jc.2003-030838 · DOI
- 10.1038/sj.onc.1206739 · DOI
- 10.1093/jnci/95.8.625 · DOI
- Yuen ST, 2002, Cancer Res, 62, 6451
- 10.1038/sj.onc.1207061 · DOI
- Wang L, 2003, Cancer Res, 63, 5209
- 10.1136/gut.52.5.706 · DOI
- 10.1002/ijc.22071 · DOI
- 10.1093/jnci/95.6.484 · DOI
- 10.1200/JCO.2008.18.8623 · DOI
- Kimura ET, 2003, Cancer Res, 63, 1454
- 10.1073/pnas.0711741105 · DOI · Paper page
- 10.1186/1479-5876-8-39 · DOI
- 10.1097/00000421-198212000-00014 · DOI
- 10.1038/nrd1496 · DOI
- 10.1016/j.cell.2009.12.040 · DOI
- 10.1038/nature08902 · DOI
- 10.1038/nature08833 · DOI
- 10.1158/0008-5472.CAN-04-1443 · DOI
- 10.1038/sj.bjc.6603291 · DOI
- 10.1200/JCO.2007.14.8288 · DOI
- 10.1200/JCO.2007.15.7636 · DOI
- 10.1056/NEJMoa050092 · DOI · Paper page
- 10.1200/JCO.2008.21.7695 · DOI
Cited by
Sorted by citations
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“More recently, the fact that a subgroup of patients with melanoma and BRAF mutations respond to specific B-RAF inhibitors has defined a new paradigm and subclass in the management of this cancer [173].”
BackgroundInnate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Self-citation
Metadata
- Authors
- Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., & Chapman, P. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-08-26
- Volume
- 363
- Issue
- 9
- Pages
- 809-819
- ISSN
- 0028-4793
- 1533-4406
- PMC
- PMC3724529
- Cited by
- 3,103
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
